Cargando…

GABA(B) receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence

The present paper summarizes the preclinical and clinical studies conducted to define the “anti-alcohol” pharmacological profile of the prototypic GABA(B) receptor agonist, baclofen, and its therapeutic potential for treatment of alcohol use disorder (AUD). Numerous studies have reported baclofen-in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agabio, Roberta, Colombo, Giancarlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047789/ https://www.ncbi.nlm.nih.gov/pubmed/24936171 http://dx.doi.org/10.3389/fnins.2014.00140

Ejemplares similares

Baclofen in the Treatment of Patients With Alcohol Use Disorder and Other Mental Health Disorders
por: Agabio, Roberta, et al.
Publicado: (2018)

A Gut Feeling about GABA: Focus on GABA(B) Receptors
por: Hyland, Niall P., et al.
Publicado: (2010)

Editorial: Baclofen in the Treatment of Alcohol Use Disorder
por: de Beaurepaire, Renaud, et al.
Publicado: (2019)

Preclinical and clinical evidence for the treatment of non-alcoholic fatty liver disease with soybean: A systematic review and meta-analysis
por: Li, Yubing, et al.
Publicado: (2023)

Peripheral Etanercept Administration Normalizes Behavior, Hippocampal Neurogenesis, and Hippocampal Reelin and GABA(A) Receptor Expression in a Preclinical Model of Depression
por: Brymer, Kyle J., et al.
Publicado: (2018)

Ligand-guided homology modelling of the GABA(B2) subunit of the GABA(B) receptor
por: Freyd, Thibaud, et al.
Publicado: (2017)

Phytosterols: From Preclinical Evidence to Potential Clinical Applications
por: Salehi, Bahare, et al.
Publicado: (2021)

Complex GABA(B) receptor complexes: how to generate multiple functionally distinct units from a single receptor
por: Xu, Chanjuan, et al.
Publicado: (2014)

Gender Differences among Sardinians with Alcohol Use Disorder
por: Agabio, Roberta, et al.
Publicado: (2021)

Opioid and GABA(B) receptors differentially couple to an adenylyl cyclase/protein kinase A downstream effector after chronic morphine treatment
por: Bagley, Elena E.
Publicado: (2014)

Targeting the Interaction of GABA(B) Receptors With CHOP After an Ischemic Insult Restores Receptor Expression and Inhibits Progressive Neuronal Death
por: Bhat, Musadiq A., et al.
Publicado: (2022)

The therapeutic potential of ultra-short-acting β-receptor antagonists in perioperative analgesic: Evidence from preclinical and clinical studies
por: Fu, Linbin, et al.
Publicado: (2022)

Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses
por: He, Xuan, et al.
Publicado: (2023)

Anti-Allergic Properties of Propolis: Evidence From Preclinical and Clinical Studies
por: Liew, Kong Yen, et al.
Publicado: (2022)

Efficacy and safety of curcumin in psoriasis: preclinical and clinical evidence and possible mechanisms
por: Zhang, Shuo, et al.
Publicado: (2022)

Preclinical Evidence of Berberine on Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Animal Studies
por: Ren, Sichen, et al.
Publicado: (2021)

The role of metabotropic glutamate receptor 5 in the pathogenesis of mood disorders and addiction: combining preclinical evidence with human Positron Emission Tomography (PET) studies
por: Terbeck, Sylvia, et al.
Publicado: (2015)

Structural mechanism of ligand activation in human GABA(B) receptor
por: Geng, Yong, et al.
Publicado: (2013)

The GABA(B) Receptor—Structure, Ligand Binding and Drug Development
por: Evenseth, Linn Samira Mari, et al.
Publicado: (2020)

Identification of amino acids involved in histamine potentiation of GABA(A) receptors
por: Thiel, Ulrike, et al.
Publicado: (2015)

Reduction by the Positive Allosteric Modulator of the GABA(B) Receptor, GS39783, of Alcohol Self-Administration in Sardinian Alcohol-Preferring Rats Exposed to the “Sipper” Procedure
por: Maccioni, Paola, et al.
Publicado: (2010)

The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders
por: Olivier, Jocelien D. A., et al.
Publicado: (2013)

Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence
por: Salehi, Bahare, et al.
Publicado: (2021)

GABA Receptor Agonists Protect From Excitotoxic Damage Induced by AMPA in Oligodendrocytes
por: Bayón-Cordero, Laura, et al.
Publicado: (2022)

Thymoquinone as a Potential Adjuvant Therapy for Cancer Treatment: Evidence from Preclinical Studies
por: Mostofa, A.G.M., et al.
Publicado: (2017)

The Novel Positive Allosteric Modulator of the GABA(B) Receptor, KK-92A, Suppresses Alcohol Self-Administration and Cue-Induced Reinstatement of Alcohol Seeking in Rats
por: Maccioni, Paola, et al.
Publicado: (2021)

Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
por: Choudhari, Amit S., et al.
Publicado: (2020)

Kininase 1 As a Preclinical Therapeutic Target for Kinin B(1) Receptor in Insulin Resistance
por: Haddad, Youssef, et al.
Publicado: (2017)

Glucosinolates From Cruciferous Vegetables and Their Potential Role in Chronic Disease: Investigating the Preclinical and Clinical Evidence
por: Connolly, Emma L., et al.
Publicado: (2021)

Neuroprotective Potentials of Panax Ginseng Against Alzheimer’s Disease: A Review of Preclinical and Clinical Evidences
por: Li, Jing, et al.
Publicado: (2021)

Duhaldea pterocaula (Franch.) Anderb. Attenuates Nociception and Inflammation via GABA(A) Receptors
por: Huang, Chunli, et al.
Publicado: (2021)

Increased Sensitivity of Mice Lacking Extrasynaptic δ-Containing GABA(A) Receptors to Histamine Receptor 3 Antagonists
por: Abdurakhmanova, Shamsiiat, et al.
Publicado: (2020)

Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy
por: Löscher, Wolfgang
Publicado: (2021)

Vortioxetine Treatment Reverses Subchronic PCP Treatment-Induced Cognitive Impairments: A Potential Role for Serotonin Receptor-Mediated Regulation of GABA Neurotransmission
por: Pehrson, Alan L., et al.
Publicado: (2018)

Corrigendum: Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
por: Choudhari, Amit S., et al.
Publicado: (2020)

Significance of Ligand-Anchored Polymers for Drug Targeting in the Treatment of Colonic Disorders
por: Chaubey, Pramila, et al.
Publicado: (2020)

Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease
por: Fuenzalida, Catalina, et al.
Publicado: (2021)

Harnessing the potential of probiotics in the treatment of alcoholic liver disorders
por: Mishra, Garima, et al.
Publicado: (2023)

GABA(A) receptor drugs and neuronal plasticity in reward and aversion: focus on the ventral tegmental area
por: Vashchinkina, Elena, et al.
Publicado: (2014)

Suppression by γ-Hydroxybutyric Acid of “Alcohol Deprivation Effect” in Rats: Preclinical Evidence of its anti-Relapse Properties
por: Colombo, Giancarlo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cvshmioorl6rdpe7f64aeo0aka